SFX by Ex Libris Inc.

Title:	Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1
Source:	Nature Immunology [1529-2908] Li, Hui-Yan yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ouyang, C. "Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation." The journal of immunology 192.6 (2014): 2846-56.
description	2.	Man, P. "CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome." EMBO Journal 26.7 (2007): 1831-42.
description	3.	Israel, A. "Signal transduction - A regulator branches out." Nature 423.6940 (2003): 596-597.
description	4.	Bouwmeester, T. "A physical and functional map of the human TNF-α/NF-κB signal transduction pathway." Nature cell biology 6.2 (2004): 97-105.
description	5.	Shou, J K. "Estrogen receptor: current understanding of its activation and modulation." Clinical cancer research 7.12 Suppl: 4338-4342.
description	6.	Murphy, L. "New insights into estrogen receptor function in human breast cancer." Annals of medicine 35.8 (2003): 614-631.
description	7.	Gavin, Giulio C. "Functional organization of the yeast proteome by systematic analysis of protein complexes." Nature 415.6868 (2002): 141-147.
description	8.	Tan, M. "Protein Phosphatase 4 Is Involved in Tumor Necrosis Factor-α-induced Activation of c-Jun N-terminal Kinase." Journal of Biological Chemistry 277.8 (2002): 6391-6398.
description	9.	Ossum, Else G. "Differential role for ERK2 in anoxia-induced activation of transcription and translation of Hsp70 in NIH 3T3 cells." Cellular physiology and biochemistry 27.2 (2011): 109-120.
description	10.	Wakeling, A. "Targeting the epidermal growth factor receptor pathway improves the anti-tumor effect of tamoxifen and delays acquired resistance in a xenograft model of breast cancer." Breast cancer research and treatment 76 (2002).
description	11.	Yeo, Leslie Y. "Microfluidic Devices for Bioapplications." Small 7.1 (2010): 12-48.
description	12.	Chia, S. "Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer." The Breast 18.2 (2009): 1-11.
description	13.	Nozaki, I. "Knockdown of nuclear Ca2ﷆꖚ蝮阩dependent protein kinase phosphatase causes developmental abnormalities in zebrafish." Archives of biochemistry and biophysics 457.2 (2006): 205-16.
description	14.	Farzaneh, L. "The strange case of TGN1412." Cancer immunology, immunotherapy 56.2 (2007): 129-134.
description	15.	Maier, P. "Cytokinesis in yeast meiosis depends on the regulated removal of Ssp1p from the prospore membrane." The EMBO journal 26.7 (2007): 1843-1852.
description	16.	O'malley, V Craig W. "Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer." Journal of clinical oncology 23.8 (2007): 5815-24.
description	17.	Rigaut, G. "A generic protein purification method for protein complex characterization and proteome exploration." Nature biotechnology 17.10 (1999): 1030-1032.
description	18.	Li, Q. "NF-κB regulation in the immune system." Nature reviews. Immunology 2.10 (2002): 725-734.
description	19.	Brandenberger, R. "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation." Nature biotechnology 22.6 (2004): 707-16.
description	20.	Black, R A A. "A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells." Nature 385.6618 (1997): 729-733.